Abstract:Wound healing can lead to hypertrophic scar or keloid formation, characterized by an overabundant extracellular matrix. Current established treatment strategies include surgical resection, triamcinolone steroid injection, pressure therapy, silicone therapy, radiotherapy, etc. Cytokines also play a critical role in the regulation of cellular activities and extracellular matrix metabolism. Interferons (IFN) represent a group of antifibroproliferative agents that inhibit fibroblast proliferation and collagen production, and interleukin (IL)-1β also accelerates hypertrophic scar fibroblasts to produce collagenolytic enzymes, leading to tissue destruction. This study addressed the effects of steroid, IFN α-2b, or IL-1β on apoptosis and cell pathway of fibroblasts from keloids, hypertrophic scars, and normal skins and different responses of different fibroblasts. Six samples of keloid, six samples of hypertrophic scar, and six samples of normal skin were, respectively, collected from patients, and fibroblasts from different sources were cultured in vitro. After different fibroblasts were treated with dexamethasone (0.1 mg/ml) or IFN α-2b (1,000 μ/ml) or IL-1β (200 μ/ml), Bax and Bcl-2 were detected in situ by immunohistochemical staining; deoxyribonucleic acid ladders of different fibroblasts were observed by gel electrophoresis, and relative activated (phospho-) extracellular-signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK) pathways were detected by the method of fast activated cell-based enzyme-linked immunosorbent assay. In media containing dexamethasone, apoptosis took place in fibroblasts from keloids, hypertrophic scars, and normal skins by gel electrophoresis with increased rate of Bax/Bcl-2. Activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions increased in three different fibroblasts. In media containing IFN α-2b, no apoptosis took place in three different fibroblasts without any change of expressions of Bax and Bcl-2 except for the expression of decreased Bcl-2 in fibroblasts from keloids. Activated (phospho-) ERK1/2 expression decreased in fibroblasts from keloid and hypertrophic scars without any changes of activated (phospho-) JNK expression, and IFN α-2b did not affect both activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions in fibroblasts from normal skin. In media containing IL-1β, apoptosis of fibroblasts from keloids was induced by stimulating activated (phospho-) ERK1/2 and activated (phospho-) JNK pathways; IL-1β could not induce apoptosis of fibroblasts from normal skin (radio of Bax/Bcl-2 decreasing) whose activated (phospho-) ERK1/2 pathway was stimulated without any changes of activated (phospho-) JNK expression. Apoptosis in fibroblasts from hypertrophic scars was induced by activating the JNK pathway and prohibiting the ERK1/2 pathway. The effects of steroid, IFN α-2b, or IL-1β on apoptosis of different fibroblasts were different through different cell signal pathways, although all of them were effective for treatment of abnormal scars.

Activation of p44/42 mitogen-activated protein kinase pathway involves in formation of hypertrophic scar and keloid

Different Roles of PKC and PKA in Effect of Interferon-Gamma on Proliferation and Collagen Synthesis of Fibroblasts.

Role of Mitogen-Activated Protein Kinases in the Formation of Hypertrophic Scar with Model of Lipopolysaccharide Stimulated Skin Fibroblast Cells

HIF-1α Promotes the Keloid Development Through the Activation of TGF-β/Smad and TLR4/MyD88/NF-κB Pathways.

Hypoxia-inducible Factor-1Α Activates Transforming Growth Factor-Β1/smad Signaling and Increases Collagen Deposition in Dermal Fibroblasts

The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.

A Study of the Abnormalities of Human Epiderm in Keloids and Hypertrophic Scars

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Studies of Transforming Growth Factors Beta 1-3 and Their Receptors I and II in Fibroblast of Keloids and Hypertrophic Scars.

Association between MeCP2 and Smad7 in the pathogenesis and development of pathological scars

The mechanism of TGF-β mediating BRD4/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression

[The Expression of Tenascin-C Mrna in Keloids and Hypertrophic Scars].

Difference in the expression of associated gene-cluster between proliferative and mature stage hypertrophic scars

CD74 fibroblasts proliferate upon mechanical stretching to promote angiogenesis in keloid

Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

Genome-wide Analysis of Dysregulated RNA-binding Proteins and Alternative Splicing Genes in Keloid

The differences and identities in genes of keloid and hypertrophic scar

Effects of Steroids, Interferon-2B, or Interluekin 1B on Apoptosis of Fibroblasts from Keloid, Hypertrophic Scars, and Normal Skin and Related Signal Pathway

CD74+ fibroblasts proliferate upon mechanical stretching to promote angiogenesis in keloids

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Dynamic changes of autophagy during hypertrophic scar formation and the role of autophagy intervention